Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Biglycan anticorps (C-Term)

BGN Reactivité: Humain WB, ELISA Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN547793
  • Antigène Voir toutes Biglycan (BGN) Anticorps
    Biglycan (BGN)
    Épitope
    • 16
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 50
    • 37
    • 32
    • 18
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 65
    • 5
    • 1
    Chèvre
    Clonalité
    • 58
    • 13
    Polyclonal
    Conjugué
    • 30
    • 14
    • 7
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Biglycan est non-conjugé
    Application
    • 55
    • 20
    • 18
    • 16
    • 13
    • 13
    • 9
    • 7
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB), ELISA
    Fonction
    Goat polyclonal antibody raised against synthetic peptide of BGN.
    Séquence
    C-DRLAIQFGNY KK
     Réactivité croisée
    Chien, Humain, Souris, Rat
    Immunogène
    A synthetic peptide corresponding to C-terminus of human BGN.
    Top Product
    Discover our top product BGN Anticorps primaire
  • Indications d'application
    ELISA (1:8000)
    Western Blot (0.1-0.3 μg/mL)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Buffer
    In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Chen, Lenschow, Tiede, Fischer, Kalthoff, Ungefroren: "Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells." dans: The Journal of biological chemistry, Vol. 277, Issue 39, pp. 36118-28, (2002) (PubMed).

  • Antigène
    Biglycan (BGN)
    Autre désignation
    Biglycan (BGN Produits)
    Synonymes
    anticorps DSPG1, anticorps PG-S1, anticorps PGI, anticorps SLRR1A, anticorps BG, anticorps BSPG1, anticorps bgn, anticorps zgc:91989, anticorps dspg1, anticorps pg-s1, anticorps slrr1a, anticorps xbgn, anticorps BGN, anticorps zgc:77123, anticorps DKFZp468I2427, anticorps biglycan, anticorps biglycan L homeolog, anticorps biglycan a, anticorps biglycan S homeolog, anticorps biglycan b, anticorps BGN, anticorps Bgn, anticorps bgn.L, anticorps bgna, anticorps bgn.S, anticorps bgn, anticorps bgnb
    ID gène
    633
    Pathways
    Glycosaminoglycan Metabolic Process
Vous êtes ici:
Support technique